Molecular Role of Carbohydrates in Acne and Seborrheic Dermatitis.

Authors

Tiffany A Kumala, Thien Ly Nguyen, Khwaja Hasan, Alisha Kashyap, Rashid M Rashid

Published in

Cureus. Volume 18. Issue 9. Pages e116420. Epub Sep 17, 2026.

Abstract

Acne vulgaris and seborrheic dermatitis are common inflammatory disorders of sebaceous skin shaped by interactions among sebaceous activity, resident microorganisms, immune signaling, and host metabolism. This narrative review examines how high-glycemic dietary exposure may influence these disorders through insulin and insulin-like growth factor-1 (IGF-1) signaling, mammalian target of rapamycin complex 1 (mTORC1), sebaceous lipogenesis, and disease-specific microbial and inflammatory pathways. In acne, observational studies, mechanistic data, and small randomized trials support a biologically plausible model in which high glycemic index (GI) or glycemic load (GL) promotes hyperinsulinemia, IGF-1 signaling, PI3K/Akt/FoxO1/mTORC1 activation, altered sebaceous lipid production, follicular keratinization, and inflammation; however, clinical dietary trials remain inconsistent. Emerging observations with glucagon-like peptide-1 receptor agonists further suggest that systemic metabolic signaling may modify inflammatory follicular disease, although these data remain preliminary. In seborrheic dermatitis, Malassezia-host interactions, sebaceous lipids, barrier dysfunction, and inflammatory signaling are well established, but direct evidence linking dietary glycemic exposure to lesional IGF-1/mTORC1 activity or disease flares is lacking. The available evidence therefore supports dietary and metabolic factors as potential disease modifiers rather than uniform causes. Dietary counseling may be considered as an adjunct in selected patients with acne, whereas disease-specific carbohydrate restriction cannot currently be recommended for seborrheic dermatitis. Controlled mechanistic and interventional studies are needed to clarify causality and identify metabolically susceptible subgroups.

PMID:
42893199
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.